REMINDER: Moleculin Announces Conference Call to Discuss Recent Breakthrough Discovery and FDA Filing on Wednesday, December 12, 2018 Dec 11, 2018
Moleculin Announces Conference Call to Discuss FDA Filing and New Immune Checkpoint Data on Wednesday, December 12, 2018 Dec 6, 2018
Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer Nov 28, 2018
Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2018 Nov 13, 2018
Moleculin Announces New Independent Study Expands Potential Use of Its Pancreatic Drug Candidate WP1122 Nov 8, 2018
